These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10211151)

  • 41. Cost of Treatment and Care for People with Alzheimer's Disease: A Meta- Analysis.
    Marešová P; Dolejs J; Mohelska H; Bryan LK
    Curr Alzheimer Res; 2019; 16(14):1245-1253. PubMed ID: 31894748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
    J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct costs of Alzheimer's disease in Germany.
    Kiencke P; Daniel D; Grimm C; Rychlik R
    Eur J Health Econ; 2011 Dec; 12(6):533-9. PubMed ID: 20640868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.
    Herrmann N; Tam DY; Balshaw R; Sambrook R; Lesnikova N; Lanctôt KL;
    Can J Psychiatry; 2010 Dec; 55(12):768-75. PubMed ID: 21172097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial.
    Søgaard R; Sørensen J; Waldorff FB; Eckermann A; Buss DV; Waldemar G
    BMC Health Serv Res; 2009 Nov; 9():215. PubMed ID: 19939249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's disease care: costs and potential savings.
    Leon J; Cheng CK; Neumann PJ
    Health Aff (Millwood); 1998; 17(6):206-16. PubMed ID: 9916370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of patient function and dependence on costs of care in Alzheimer's disease.
    Zhu CW; Leibman C; McLaughlin T; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2008 Aug; 56(8):1497-503. PubMed ID: 18662215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
    Kosaner Kließ M; Martins R; Connolly MP
    J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's disease: the strength of association of costs with different measures of disease severity.
    Mauskopf J; Racketa J; Sherrill E
    J Nutr Health Aging; 2010 Oct; 14(8):655-63. PubMed ID: 20922342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG; Toumi I; Hemels ME
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
    Reed C; Happich M; Argimon JM; Haro JM; Wimo A; Bruno G; Dodel R; Jones RW; Vellas B; Belger M
    J Alzheimers Dis; 2017; 57(3):797-812. PubMed ID: 28304285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Training care givers of stroke patients: economic evaluation.
    Patel A; Knapp M; Evans A; Perez I; Kalra L
    BMJ; 2004 May; 328(7448):1102. PubMed ID: 15130978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments.
    McNamee P; Vanoli A; Hutchings D; McKeith I; Bond J
    J Nutr Health Aging; 2010 Oct; 14(8):664-8. PubMed ID: 20922343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.
    Allegri RF; Butman J; Arizaga RL; Machnicki G; Serrano C; Taragano FE; Sarasola D; Lon L
    Int Psychogeriatr; 2007 Aug; 19(4):705-18. PubMed ID: 16870037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Jia J; Wei C; Chen S; Li F; Tang Y; Qin W; Zhao L; Jin H; Xu H; Wang F; Zhou A; Zuo X; Wu L; Han Y; Han Y; Huang L; Wang Q; Li D; Chu C; Shi L; Gong M; Du Y; Zhang J; Zhang J; Zhou C; Lv J; Lv Y; Xie H; Ji Y; Li F; Yu E; Luo B; Wang Y; Yang S; Qu Q; Guo Q; Liang F; Zhang J; Tan L; Shen L; Zhang K; Zhang J; Peng D; Tang M; Lv P; Fang B; Chu L; Jia L; Gauthier S
    Alzheimers Dement; 2018 Apr; 14(4):483-491. PubMed ID: 29433981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.
    Kirson NY; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Ye W; Andrews JS; Ball D; Kahle-Wrobleski K
    BMC Geriatr; 2016 Jul; 16():138. PubMed ID: 27400711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.